These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35077762)

  • 21. Artemether Activation of AMPK/GSK3
    Li S; Zhao X; Lazarovici P; Zheng W
    Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction.
    Chiang MC; Cheng YC; Chen SJ; Yen CH; Huang RN
    Exp Cell Res; 2016 Oct; 347(2):322-31. PubMed ID: 27554603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex.
    Hettich MM; Matthes F; Ryan DP; Griesche N; Schröder S; Dorn S; Krauβ S; Ehninger D
    PLoS One; 2014; 9(7):e102420. PubMed ID: 25025689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.
    Son SM; Shin HJ; Byun J; Kook SY; Moon M; Chang YJ; Mook-Jung I
    J Alzheimers Dis; 2016; 51(4):1197-208. PubMed ID: 26967226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.
    Gu JL; Liu F
    Curr Med Sci; 2020 Dec; 40(6):1009-1021. PubMed ID: 33428128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
    Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
    Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.
    Chen Y; Zhou K; Wang R; Liu Y; Kwak YD; Ma T; Thompson RC; Zhao Y; Smith L; Gasparini L; Luo Z; Xu H; Liao FF
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3907-12. PubMed ID: 19237574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
    Fan SJ; Huang FI; Liou JP; Yang CR
    Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease-related brain insulin resistance and the prospective therapeutic impact of metformin.
    Abosharaf HA; Elsonbaty Y; Tousson E; M Mohamed T
    J Neuroendocrinol; 2024 Jan; 36(1):e13356. PubMed ID: 37985011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective Natural Products for Alzheimer's Disease.
    Chen X; Drew J; Berney W; Lei W
    Cells; 2021 May; 10(6):. PubMed ID: 34070275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
    Sodhi RK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):115-24. PubMed ID: 21607645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review].
    Ishmuratova AN; Abramov MA; Kuznetsov KO; Ivanyuta MV; Shakirova ZF; Kitapova AI; Usmonov MD; Chernousova LM; Valeeva LI; Kuznetsova AY; Baislamov AS; Shaihetdinova AR; Mirgaliev AA; Orozberdiev ST; Yakupova KI
    Probl Endokrinol (Mosk); 2023 Nov; 69(5):73-83. PubMed ID: 37968954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease.
    Iyaswamy A; Krishnamoorthi SK; Zhang H; Sreenivasmurthy SG; Zhu Z; Liu J; Su CF; Guan XJ; Wang ZY; Cheung KH; Song JX; Durairajan SSK; Li M
    Phytomedicine; 2021 Oct; 91():153648. PubMed ID: 34332287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.